93 related articles for article (PubMed ID: 29663738)
1. Expression of amyloid precursor-like protein 2 (APLP2) in glioblastoma is associated with patient prognosis.
Chen Y; Wang H; Tan C; Yan Y; Shen J; Huang Q; Xu T; Lin J; Chen J
Folia Neuropathol; 2018; 56(1):30-38. PubMed ID: 29663738
[TBL] [Abstract][Full Text] [Related]
2. Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.
Tsidulko AY; Kazanskaya GM; Kostromskaya DV; Aidagulova SV; Kiselev RS; Volkov AM; Kobozev VV; Gaitan AS; Krivoshapkin AL; Grigorieva EV
Tumour Biol; 2017 Sep; 39(9):1010428317724282. PubMed ID: 28945172
[TBL] [Abstract][Full Text] [Related]
3. High Jagged1 expression is associated with poor outcome in primary glioblastoma.
Qiu XX; Wang CH; You N; Chen BJ; Wang XF; Chen YP; Lin ZX
Med Oncol; 2015 Jan; 32(1):341. PubMed ID: 25424769
[TBL] [Abstract][Full Text] [Related]
4. The transcription factor PPARα is overexpressed and is associated with a favourable prognosis in IDH-wildtype primary glioblastoma.
Haynes HR; White P; Hares KM; Redondo J; Kemp KC; Singleton WGB; Killick-Cole CL; Stevens JR; Garadi K; Guglani S; Wilkins A; Kurian KM
Histopathology; 2017 Jun; 70(7):1030-1043. PubMed ID: 27926792
[TBL] [Abstract][Full Text] [Related]
5. Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival.
Wangaryattawanich P; Hatami M; Wang J; Thomas G; Flanders A; Kirby J; Wintermark M; Huang ES; Bakhtiari AS; Luedi MM; Hashmi SS; Rubin DL; Chen JY; Hwang SN; Freymann J; Holder CA; Zinn PO; Colen RR
Neuro Oncol; 2015 Nov; 17(11):1525-37. PubMed ID: 26203066
[TBL] [Abstract][Full Text] [Related]
6. High IFIT1 expression predicts improved clinical outcome, and IFIT1 along with MGMT more accurately predicts prognosis in newly diagnosed glioblastoma.
Zhang JF; Chen Y; Lin GS; Zhang JD; Tang WL; Huang JH; Chen JS; Wang XF; Lin ZX
Hum Pathol; 2016 Jun; 52():136-44. PubMed ID: 26980050
[TBL] [Abstract][Full Text] [Related]
7. Wnt5a, Ryk and Ror2 expression in glioblastoma subgroups.
Kim Y; Hong M; Do IG; Ha SY; Lee D; Suh YL
Pathol Res Pract; 2015 Dec; 211(12):963-72. PubMed ID: 26596412
[TBL] [Abstract][Full Text] [Related]
8. Epilysin is overexpressed in glioblastoma and related to clinical outcome of patients.
Wang X; Zhang K; Chen X; Zhao C; Sun Z
Med Oncol; 2015 Jan; 32(1):363. PubMed ID: 25429835
[TBL] [Abstract][Full Text] [Related]
9. High expression of TIG3 predicts poor survival in patients with primary glioblastoma.
Wang H; Xu H; Xu T; Tan C; Jiang M; Chen Y; Hu X; Zhou J; Shen J; Qin R; Hu D; Huang Q; Wang M; Wang L; Duan D; Yan Y; Chen J
Tumour Biol; 2017 Jun; 39(6):1010428317712135. PubMed ID: 28639915
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of G-protein-coupled receptors 65 in glioblastoma predicts poor patient prognosis.
Wang HX; Chen YH; Zhou JX; Hu XY; Tan C; Yan Y; Huang QL; Shen JY; Xu HC; Li F; Gong ZY; Xu T; Chen JX
Clin Neurol Neurosurg; 2018 Jan; 164():132-137. PubMed ID: 29223793
[TBL] [Abstract][Full Text] [Related]
11. Extent of tumor removal and molecular markers in cerebral glioblastoma: a combined prognostic factors study in a surgical series of 105 patients.
Salvati M; Pichierri A; Piccirilli M; Floriana Brunetto GM; D'Elia A; Artizzu S; Santoro F; Arcella A; Giangaspero F; Frati A; Simione L; Santoro A
J Neurosurg; 2012 Aug; 117(2):204-11. PubMed ID: 22655594
[TBL] [Abstract][Full Text] [Related]
12. The hedgehog antagonist HHIP as a favorable prognosticator in glioblastoma.
Chang L; Zhang P; Zhao D; Liu H; Wang Q; Li C; Du W; Liu X; Zhang H; Zhang Z; Jiang C
Tumour Biol; 2016 Mar; 37(3):3979-86. PubMed ID: 26482617
[TBL] [Abstract][Full Text] [Related]
13. Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy.
Nguyen HN; Lie A; Li T; Chowdhury R; Liu F; Ozer B; Wei B; Green RM; Ellingson BM; Wang HJ; Elashoff R; Liau LM; Yong WH; Nghiemphu PL; Cloughesy T; Lai A
Neuro Oncol; 2017 Mar; 19(3):394-404. PubMed ID: 27571882
[TBL] [Abstract][Full Text] [Related]
14. High expression of N-myc (and STAT) interactor predicts poor prognosis and promotes tumor growth in human glioblastoma.
Meng D; Chen Y; Yun D; Zhao Y; Wang J; Xu T; Li X; Wang Y; Yuan L; Sun R; Song X; Huai C; Hu L; Yang S; Min T; Chen J; Chen H; Lu D
Oncotarget; 2015 Mar; 6(7):4901-19. PubMed ID: 25669971
[TBL] [Abstract][Full Text] [Related]
15. Serum amyloid A1 is upregulated in human glioblastoma.
Knebel FH; Uno M; Galatro TF; Bellé LP; Oba-Shinjo SM; Marie SKN; Campa A
J Neurooncol; 2017 May; 132(3):383-391. PubMed ID: 28283801
[TBL] [Abstract][Full Text] [Related]
16. Polysialic acid neural cell adhesion molecule (PSA-NCAM) is an adverse prognosis factor in glioblastoma, and regulates olig2 expression in glioma cell lines.
Amoureux MC; Coulibaly B; Chinot O; Loundou A; Metellus P; Rougon G; Figarella-Branger D
BMC Cancer; 2010 Mar; 10():91. PubMed ID: 20219118
[TBL] [Abstract][Full Text] [Related]
17. High delta-like ligand 4 (DLL4) is correlated with peritumoral brain edema and predicts poor prognosis in primary glioblastoma.
Qiu XX; Chen L; Wang CH; Lin ZX; Zhou CF; Liu SY; Wang XF; Chen YP
Medicine (Baltimore); 2014 Aug; 93(8):e57. PubMed ID: 25121357
[TBL] [Abstract][Full Text] [Related]
18. High neuronatin (NNAT) expression is associated with poor outcome in breast cancer.
Nass N; Walter S; Jechorek D; Weissenborn C; Ignatov A; Haybaeck J; Sel S; Kalinski T
Virchows Arch; 2017 Jul; 471(1):23-30. PubMed ID: 28540450
[TBL] [Abstract][Full Text] [Related]
19. Treatment and survival of patients harboring histological variants of glioblastoma.
Ortega A; Nuño M; Walia S; Mukherjee D; Black KL; Patil CG
J Clin Neurosci; 2014 Oct; 21(10):1709-13. PubMed ID: 24980627
[TBL] [Abstract][Full Text] [Related]
20. STAT3 serine 727 phosphorylation influences clinical outcome in glioblastoma.
Lin GS; Chen YP; Lin ZX; Wang XF; Zheng ZQ; Chen L
Int J Clin Exp Pathol; 2014; 7(6):3141-9. PubMed ID: 25031733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
